Patents/Assignees

Eil Therapeutics, Inc.

2 patents in portfolio

US11834450utility2023
Compounds Having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 Inhibitors
0 cites
US11697650utility2023
Compounds Having Tetrahydroindolizine-1-carboxamide as BCL-2 Inhibitors
0 cites